• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Author's Reply to Reith: "Higher Midazolam Clearance in Obese Adolescents Compared with Morbidly Obese Adults".

作者信息

van Rongen Anne, van den Anker Johannes N, Knibbe Catherijne A J

机构信息

Department of Clinical Pharmacy, Reinier de Graaf Hospital, Delft, The Netherlands.

Intensive Care and Department of Pediatric Surgery, Erasmus MC Sophia Children's Hospital, Rotterdam, The Netherlands.

出版信息

Clin Pharmacokinet. 2018 Oct;57(10):1357-1358. doi: 10.1007/s40262-018-0692-z.

DOI:10.1007/s40262-018-0692-z
PMID:29936679
Abstract
摘要

相似文献

1
Author's Reply to Reith: "Higher Midazolam Clearance in Obese Adolescents Compared with Morbidly Obese Adults".作者对赖思的回复：“与病态肥胖成年人相比，肥胖青少年咪达唑仑清除率更高” 。
Clin Pharmacokinet. 2018 Oct;57(10):1357-1358. doi: 10.1007/s40262-018-0692-z.
2
Higher Midazolam Clearance in Obese Adolescents Compared with Morbidly Obese Adults.肥胖青少年咪达唑仑清除率高于病态肥胖成年人。
Clin Pharmacokinet. 2018 May;57(5):601-611. doi: 10.1007/s40262-017-0579-4.
3
Comment on van Rongen et al., "Higher Midazolam Clearance in Obese Adolescents Compared with Morbidly Obese Adults".对范龙根等人的评论，“与病态肥胖成年人相比，肥胖青少年咪达唑仑清除率更高”。
Clin Pharmacokinet. 2018 Oct;57(10):1355. doi: 10.1007/s40262-018-0691-0.
4
Author's Reply to Reith: "Morbidly Obese Patients Exhibit Increased CYP2E1-Mediated Oxidation of Acetaminophen".作者对赖斯的回复：“病态肥胖患者对乙酰氨基酚的CYP2E1介导氧化增加”
Clin Pharmacokinet. 2018 Jul;57(7):897-899. doi: 10.1007/s40262-018-0665-2.
5
Population pharmacokinetics of midazolam and its metabolites in overweight and obese adolescents.咪达唑仑及其代谢产物在超重和肥胖青少年中的群体药代动力学。
Br J Clin Pharmacol. 2015 Nov;80(5):1185-96. doi: 10.1111/bcp.12693. Epub 2015 Sep 10.
6
Semiphysiologically based pharmacokinetic model for midazolam and CYP3A mediated metabolite 1-OH-midazolam in morbidly obese and weight loss surgery patients.病态肥胖及减肥手术患者中咪达唑仑和CYP3A介导的代谢物1-羟基咪达唑仑的半生理药代动力学模型
CPT Pharmacometrics Syst Pharmacol. 2016 Jan;5(1):20-30. doi: 10.1002/psp4.12048. Epub 2015 Dec 18.
7
Propofol clearance in morbidly obese children and adolescents: influence of age and body size.肥胖儿童和青少年丙泊酚清除率：年龄和体型的影响。
Clin Pharmacokinet. 2012 Aug 1;51(8):543-51. doi: 10.2165/11632940-000000000-00000.
8
Pharmacokinetic and pharmacodynamics of intravenous dexmedetomidine in morbidly obese patients undergoing laparoscopic surgery.静脉注射右美托咪定在接受腹腔镜手术的病态肥胖患者中的药代动力学和药效学
J Anesth. 2017 Dec;31(6):813-820. doi: 10.1007/s00540-017-2399-y. Epub 2017 Aug 21.
9
Airway topicalisation in morbidly obese patients using atomised lidocaine: 2% compared with 4%.使用雾化利多卡因对病态肥胖患者进行气道表面麻醉：2%与4%的比较。
Anaesthesia. 2007 Oct;62(10):984-8. doi: 10.1111/j.1365-2044.2007.05179.x.
10
Author's reply: To PMID 23513321.作者回复：针对 PMID 23513321。
AANA J. 2013 Aug;81(4):257-8.

本文引用的文献

1
Higher Midazolam Clearance in Obese Adolescents Compared with Morbidly Obese Adults.肥胖青少年咪达唑仑清除率高于病态肥胖成年人。
Clin Pharmacokinet. 2018 May;57(5):601-611. doi: 10.1007/s40262-017-0579-4.
2
Changes in duration of action of rocuronium following decrease in hepatic blood flow during pneumoperitoneum for laparoscopic gynaecological surgery.腹腔镜妇科手术气腹期间肝血流减少后罗库溴铵作用持续时间的变化
BMC Anesthesiol. 2017 Mar 20;17(1):45. doi: 10.1186/s12871-017-0335-1.
3
The Pharmacokinetics of the CYP3A Substrate Midazolam in Morbidly Obese Patients Before and One Year After Bariatric Surgery.
CYP3A底物咪达唑仑在病态肥胖患者减肥手术前及术后一年的药代动力学
Pharm Res. 2015 Dec;32(12):3927-36. doi: 10.1007/s11095-015-1752-9. Epub 2015 Jul 23.
4
Midazolam pharmacokinetics in morbidly obese patients following semi-simultaneous oral and intravenous administration: a comparison with healthy volunteers.病态肥胖患者口服与静脉半同步给药后咪达唑仑的药代动力学：与健康志愿者的比较
Clin Pharmacokinet. 2014 Oct;53(10):931-41. doi: 10.1007/s40262-014-0166-x.
5
Effects of oral clotrimazole troches on the pharmacokinetics of oral and intravenous midazolam.克霉唑口含片对口服和静脉注射咪达唑仑药代动力学的影响。
Br J Clin Pharmacol. 2010 Feb;69(2):160-6. doi: 10.1111/j.1365-2125.2009.03559.x.
6
Application of semisimultaneous midazolam administration for hepatic and intestinal cytochrome P450 3A phenotyping.半同步给予咪达唑仑在肝脏和肠道细胞色素P450 3A表型分析中的应用。
Clin Pharmacol Ther. 2002 Dec;72(6):718-28. doi: 10.1067/mcp.2002.129068.
7
Integrated pharmacokinetics and pharmacodynamics of Ro 48-8684, a new benzodiazepine, in comparison with midazolam during first administration to healthy male subjects.新型苯二氮䓬类药物Ro 48 - 8684与咪达唑仑在首次给药于健康男性受试者时的药代动力学和药效学整合比较。
Br J Clin Pharmacol. 1997 Nov;44(5):487-93. doi: 10.1046/j.1365-2125.1997.t01-1-00613.x.
8
Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism.咪达唑仑的口服首过消除涉及胃肠道和肝脏中细胞色素P450 3A（CYP3A）介导的代谢。
Clin Pharmacol Ther. 1996 May;59(5):491-502. doi: 10.1016/S0009-9236(96)90177-0.
9
Regioselective biotransformation of midazolam by members of the human cytochrome P450 3A (CYP3A) subfamily.人细胞色素P450 3A（CYP3A）亚家族成员对咪达唑仑的区域选择性生物转化。
Biochem Pharmacol. 1994 Apr 29;47(9):1643-53. doi: 10.1016/0006-2952(94)90543-6.
10
Effect of age, gender, and obesity on midazolam kinetics.年龄、性别和肥胖对咪达唑仑动力学的影响。
Anesthesiology. 1984 Jul;61(1):27-35.